Target intelligence / Profile preview

ADP-ribosylation factor-like protein 16 (ARL16)

Target
ARL16
Molecular classification
Small GTPase, ARF family (ADP-ribosylation factor family), Ras superfamily GTPase
01

Overview

ADP-ribosylation factor-like protein 16 (ARL16) is a member of the ARF family of small GTPases within the Ras superfamily[1][3]. It is an evolutionarily conserved protein found in virtually all ciliated eukaryotes, where it localizes mainly to cilia, basal bodies, and Golgi apparatus[1][2]. Its primary recognized function is the regulation of trafficking of specific proteins (including IFT140 and INPP5E) from the Golgi to the cilium, influencing cilia structure, composition, and signaling[1][2]. Loss of ARL16 impairs cilia formation, alters ciliary protein profiles, and affects key ciliary and signaling pathways such as Hedgehog signaling[1][2]. ARL16 also acts as a negative regulator of the RIG-I pathway, thereby modulating innate immune signaling through direct inhibition of RIG-I in a GTP-dependent manner[3]. No disease is directly caused by ARL16 mutations, and it is not currently a therapeutic target or biomarker, nor are there approved drugs acting through it. Its functional importance in ciliary protein sorting and immune regulation suggests a role in disorders of cilia or immunity, but this remains to be clarified by future research[1][2][3].

Other names
ADP ribosylation factor like GTPase 16ARL16ADP-ribosylation factor-like protein 16
02

Biological functions

Regulation of ciliary protein trafficking (Golgi–cilia pathway)Modulation of ciliary protein compositionInhibition of RIG-I mediated innate immune signaling
03

Disease associations

Other (no direct disease link, but indirectly involved in ciliary and immune signaling; disruption may impact ciliopathies or immune response)

Beyond the preview

Go deeper on ADP-ribosylation factor-like protein 16 (ARL16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor-like protein 16 (ARL16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call